Remove Competition Remove Conference Remove Pricing Remove San Diego
article thumbnail

Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?

Xconomy

With the 2020 election just over a year away, House Speaker Nancy Pelosi (D-CA) has unveiled the Democratic Party’s answer to public discontent over high prescription drug prices. In a press conference Thursday, Pelosi (pictured. A preview of the plan was leaked last week. Today’s announcement doesn’t stray far.

Pricing 67
article thumbnail

Bio Roundup: Drug Pricing, Cystic Fibrosis Showdown, Myovant & More

Xconomy

—As the North American Cystic Fibrosis Conference kicked off in Orlando, FL, Vertex Pharmaceuticals (NASDAQ: VRTX ) said a key part of its plan to defend its industry-leading cystic fibrosis franchise is moving forward. THIS WEEK IN DRUG PRICING…. —A coalition of investors pressed drug makers to justify price increases.

Pricing 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biotech Roundup: Deals Gone Wrong, Ethical Red Flags & Bay Goodbyes

Xconomy

This weekend, much of academia and industry involved in cancer will gather in Chicago for the annual American Society of Clinical Oncology conference. Thousands of others will head to San Francisco for BIO, which has a distinct international flavor. billion acquisition of San Diego’s Auspex Pharmaceuticals last year.

article thumbnail

Is the Future of Cybersecurity in M&A?

Xconomy

This has been evident with recent acquisitions beyond Symantec and Blue Coat – Avast and AVG, Cisco and CloudLock , IBM and Resilient Systems , and most recently Carbon Black and Confer. Symantec Forces the Industry to Stay Competitive. A Startup’s Opportunity to Thrive.

article thumbnail

Bio Roundup: Jenkins Gets Mad, Bernie Gets His Pen, CRISPR IPO & J-Lo

Xconomy

The staff also crowed over Clinton’s tweet—a reaction last summer to the first revelations about Martin Shkreli’s price gouging —that sent biopharma stocks downhill. The hikes were first reported earlier this month by Adam Feuerstein of The Street. Wait til you get a load of this week’s roundup. TOP STORIES.

article thumbnail

Some Thoughts on Leadership Going into 2016

Both Sides of the Table

In fact, 50% of our investments are in Southern California, from Santa Barbara to San Diego. She can anticipate reactions to price increases or product changes by customers and she can sustain competitive challenges because she knows the customer will stick by her. They attend conferences and do marketing.

Startup 150